GSK’s HIV venture fails to get USFDA approval for once-a-month injection
The HIV venture led by GlaxoSmithKline Plc failed to win US approval for a once-a-month injection that aims to free patients from daily doses of medication. ViiV Healthcare received a complete resp…
